secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2023-04-24T23:59:59+00:00
Accession:  0001140361-23-019943
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano preliminary Q1 revenue $7.3-7.5M, up 28-32% YoY; withdraws CPT code applications
--------------------------------------------------------------------------------

- Preliminary Q1 revenue $7.3-7.5M, representing 10th consecutive YoY growth quarter.
- Saphyr installed base 259 as of March 31 (+47% YoY); 19 systems added in Q1.
- Preliminary flowcell sales of 5,226, up 62% over Q1 2022.
- Withdraws Category I CPT code applications for OGM to avoid Category III assignment; evaluating new strategy.
- Reaffirms FY 2023 guidance: revenue $35-38M and 325 OGM system installed base target.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123019943/0001140361-23-019943-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123019943/brhc20051859_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-019943

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer